| Literature DB >> 35203144 |
Miguel L Grilo1,2, Guadalupe Amaro1, Lélia Chambel3, Carolina S Marques4, Tiago A Marques4,5, Fátima Gil6, Carla Sousa-Santos2, Joana I Robalo2, Manuela Oliveira1.
Abstract
Ex situ breeding programs are important conservation tools for endangered freshwater fish. However, developing husbandry techniques that decrease the likelihood of disease, antimicrobial resistance, and virulence determinants acquisition during this process is challenging. In this pilot study, we conducted a captivity experiment with Portuguese nase (Iberochondrostoma lusitanicum), a critically endangered leuciscid species, to investigate the influence of simple protective measures (i.e., material disinfection protocols and animal handling with gloves) on the dynamics of a potential pathogenic genus, Aeromonas, as well as its virulence profiles and antimicrobial resistance signatures. Our findings show that antimicrobial resistance in Aeromonas spp. collected from I. lusitanicum significantly increased during the extent of the assay (5 weeks), with all isolates collected at the end of the study classified as multidrug-resistant. Additionally, humans handling fishes without protective measures were colonized by Aeromonas spp. The use of protective measures suggested a decreasing trend in Aeromonas spp. prevalence in I. lusitanicum, while bacterial isolates displayed significantly lower virulence index values when virulence phenotypical expression was tested at 22 °C. Despite this study representing an initial trial, which needs support from further research, protective measures tested are considered a simple tool to be applied in ex situ breeding programs for aquatic animals worldwide. Furthermore, current results raise concern regarding antimicrobial resistance amplification and zoonotic transmission of Aeromonas spp. in aquatic ex situ programs.Entities:
Keywords: Aeromonas spp.; Iberochondrostoma lusitanicum; antimicrobial resistance; ex situ; virulence
Year: 2022 PMID: 35203144 PMCID: PMC8868083 DOI: 10.3390/ani12040436
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Experimental conditions in this study.
| Action | Control Tank | Test Tank |
|---|---|---|
| Tank covering | Fine mesh | Plastic cover |
| Food preparation | Food items thawed with tap water in non-disinfected containers | Food items thawed with sterile water transported in sterile shots in containers disinfected with 70% ethanol and exposed to UV radiation |
| Water renovation and food surplus retrieval | Water and food pumped out of the tank with a non-disinfected suction system | Water and food pumped out of the tank with a suction system disinfected with 70% ethanol and exposed to UV radiation |
| Fish handling | Operator not using gloves and using non-disinfected shrimp nets and handling tanks | Operator using nitrile gloves and handling tanks disinfected with 70% ethanol and shrimp nets disinfected with 70% ethanol and exposed to UV radiation |
| Fish sampling | Measuring device non-disinfected | Measuring device disinfected with 70% ethanol |
Figure 1Aeromonas spp. prevalence in both tanks across the sampling weeks.
Figure 2Relative prevalence of Aeromonas species by tank and sampling week.
Figure 3Virulence index of the isolates collected in both tanks in the 1st and 5th week and analyzed at 22 °C (A) and 37 °C (B). ** p < 0.01.
Figure 4Relative prevalence of virulence factors by tank and sampling week of the isolates analyzed at 22 °C (A) and 37 °C (B). H—hemolytic activity, L—lipase activity, G—gelatinase activity, P—protease activity, S—slime production.
Figure 5MAR index values (mean + SEM) of the isolates collected in both tanks across the sampling weeks.
Figure 6Relative prevalence of non-susceptibility to the tested antimicrobial compounds of the isolates collected in both tanks across the sampling weeks. AK—amikacin, AUG—amoxicillin/clavulanic acid, ATM—aztreonam, CAZ—ceftazidime, E—erythromycin, ENF—enrofloxacin, FFC—florfenicol, IMI—imipenem, NI—nitrofurantoin, S—streptomycin, T—tetracycline, TS—sulfamethoxazole/trimethoprim.